Oct 20 (Reuters) – Basilea Pharmaceutica AG, Allschwil : * BASILEA REPORTS PRESENTATION OF NEW DATA FOR FOSMANOGEPIX, ISAVUCONAZOLE AND CEFTOBIPROLE AT IDWEEK 2026 Source text: Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 20 (Reuters) - Mabion SA: * PARTNER ODDIFACT SAYS FDA CONSULTATIONS ALLOW MABIONCD20 TO…
ABB posts record quarterly orders helped by data centre boom
By John Revill ZURICH, Oct 20 (Reuters) - ABB said on Tuesday a boom in…
Analysis-As Japan pursues a chip-industry reboot, it's being pressed to build America's
By Kentaro Okasaka and Tamiyuki Kihara TOKYO, Oct 20 (Reuters) - Japan is in the…
